TY - JOUR
T1 - Anesthetic considerations in children with asthma
AU - Regli, Adrian
AU - Sommerfield, Aine
AU - von Ungern-Sternberg, Britta S.
N1 - Funding Information:
BSvUS is partly funded by the Stan Perron Charitable Trust.
Publisher Copyright:
© 2021 John Wiley & Sons Ltd.
PY - 2022/2
Y1 - 2022/2
N2 - Due to the high prevalence of asthma and general airway reactivity, anesthesiologists frequently encounter children with asthma or asthma-like symptoms. This review focuses on the epidemiology, the underlying pathophysiology, and perioperative management of children with airway reactivity, including controlled and uncontrolled asthma. It spans from preoperative optimization to optimized intraoperative management, airway management, and ventilation strategies. There are three leading causes for bronchospasm (1) mechanical (eg, airway manipulation), (2) non-immunological anaphylaxis (anaphylactoid reaction), and (3) immunological anaphylaxis. Children with increased airway reactivity may benefit from a premedication with beta-2 agonists, non-invasive airway management, and deep removal of airway devices. While desflurane should be avoided in pediatric anesthesia due to an increased risk of bronchospasm, other volatile agents are potent bronchodilators. Propofol is superior in blunting airway reflexes and, therefore, well suited for anesthesia induction in children with increased airway reactivity.
AB - Due to the high prevalence of asthma and general airway reactivity, anesthesiologists frequently encounter children with asthma or asthma-like symptoms. This review focuses on the epidemiology, the underlying pathophysiology, and perioperative management of children with airway reactivity, including controlled and uncontrolled asthma. It spans from preoperative optimization to optimized intraoperative management, airway management, and ventilation strategies. There are three leading causes for bronchospasm (1) mechanical (eg, airway manipulation), (2) non-immunological anaphylaxis (anaphylactoid reaction), and (3) immunological anaphylaxis. Children with increased airway reactivity may benefit from a premedication with beta-2 agonists, non-invasive airway management, and deep removal of airway devices. While desflurane should be avoided in pediatric anesthesia due to an increased risk of bronchospasm, other volatile agents are potent bronchodilators. Propofol is superior in blunting airway reflexes and, therefore, well suited for anesthesia induction in children with increased airway reactivity.
KW - anesthesia
KW - asthma
KW - bronchial hyperreactivity
KW - bronchoconstriction
KW - bronchospasm
KW - increased airway reactivity
KW - pediatric
KW - ventilation
UR - http://www.scopus.com/inward/record.url?scp=85121030098&partnerID=8YFLogxK
U2 - 10.1111/pan.14373
DO - 10.1111/pan.14373
M3 - Review article
C2 - 34890494
AN - SCOPUS:85121030098
SN - 1155-5645
VL - 32
SP - 148
EP - 155
JO - Paediatric Anaesthesia
JF - Paediatric Anaesthesia
IS - 2
ER -